WHO ICTRP trial
Serological screening and metabolic analysis for evaluation of the immune…
DRKS00022292 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00022292 |
|---|---|
| Public title | Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19) |
| Scientific title | Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19) |
| Primary sponsor | Universitätsklinikum Freiburg Klinik für Innere Medizin I |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | COVID-19 |
| Interventions | Group 1: subjects exposed to SARS-CoV2 (contact with SARS-CoV2-infected people) Group 2: historic controls (biomaterial from 2019 or earlier available) |
| Registration date | Jun 26, 2020 |
| Target size | 250 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: